|
Bicycle Therapeutics PLC (BCYC) DCF Avaliação
GB | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Bicycle Therapeutics plc (BCYC) Bundle
Avalie as perspectivas financeiras da Bicycle Therapeutics plc (BCYC) como um especialista! Esta calculadora DCF (BCYC) fornece dados financeiros pré-preenchidos e flexibilidade total para modificar o crescimento da receita, WACC, margens e outras suposições essenciais para corresponder às suas projeções.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.4 | 11.7 | 14.5 | 27.0 | 35.3 | 48.8 | 67.5 | 93.5 | 129.3 | 179.0 |
| Revenue Growth, % | 0 | 12.58 | 23.65 | 86.52 | 30.76 | 38.38 | 38.38 | 38.38 | 38.38 | 38.38 |
| EBITDA | -50.4 | -64.1 | -113.0 | -183.4 | -164.9 | -48.8 | -67.5 | -93.5 | -129.3 | -179.0 |
| EBITDA, % | -484.98 | -547.84 | -781.06 | -679.86 | -467.45 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.3 | 1.4 | 3.7 | 6.5 | 7.2 | 9.2 | 12.8 | 17.7 | 24.5 | 33.8 |
| Depreciation, % | 12.39 | 12.04 | 25.49 | 24.27 | 20.34 | 18.9 | 18.9 | 18.9 | 18.9 | 18.9 |
| EBIT | -51.7 | -65.5 | -116.7 | -189.9 | -172.1 | -48.8 | -67.5 | -93.5 | -129.3 | -179.0 |
| EBIT, % | -497.36 | -559.89 | -806.55 | -704.13 | -487.78 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 136.0 | 438.7 | 339.2 | 526.4 | 879.5 | 48.8 | 67.5 | 93.5 | 129.3 | 179.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 14.6 | 11.9 | 21.2 | 24.0 | 35.7 | 47.7 | 66.1 | 91.4 | 126.5 | 175.1 |
| Account Receivables, % | 140.84 | 101.82 | 146.63 | 89.11 | 101.07 | 97.82 | 97.82 | 97.82 | 97.82 | 97.82 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0.000006914195 | 0 | 0 | 0.000001382839 | 0.000001382839 | 0.000001382839 | 0.000001382839 | 0.000001382839 |
| Accounts Payable | 1.4 | 2.7 | 6.5 | 13.1 | 15.8 | 17.0 | 23.5 | 32.6 | 45.1 | 62.4 |
| Accounts Payable, % | 13.14 | 23.26 | 44.75 | 48.38 | 44.77 | 34.86 | 34.86 | 34.86 | 34.86 | 34.86 |
| Capital Expenditure | -1.2 | -2.0 | -19.0 | -2.9 | -1.2 | -14.0 | -19.4 | -26.8 | -37.1 | -51.3 |
| Capital Expenditure, % | -11.55 | -17.35 | -131.28 | -10.86 | -3.5 | -28.65 | -28.65 | -28.65 | -28.65 | -28.65 |
| Tax Rate, % | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 |
| EBITAT | -51.0 | -63.9 | -115.1 | -191.5 | -167.3 | -48.0 | -66.5 | -92.0 | -127.3 | -176.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -64.1 | -60.4 | -135.9 | -184.1 | -170.3 | -63.7 | -84.9 | -117.4 | -162.5 | -224.8 |
| WACC, % | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -490.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -229 | |||||||||
| Terminal Value | -3,571 | |||||||||
| Present Terminal Value | -2,383 | |||||||||
| Enterprise Value | -2,874 | |||||||||
| Net Debt | -876 | |||||||||
| Equity Value | -1,999 | |||||||||
| Diluted Shares Outstanding, MM | 582 | |||||||||
| Equity Value Per Share | -3.43 |
What You Will Receive
- Adjustable Forecast Parameters: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Comprehensive Data: Bicycle Therapeutics plc's (BCYC) financial data pre-loaded to facilitate your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Flexible and Professional Design: A refined Excel model that can be tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and R&D expenditures.
- Instant Valuation Model: Generates intrinsic value, NPV, and other key metrics automatically.
- High-Precision Analytics: Leverages Bicycle Therapeutics' (BCYC) actual financial data for accurate valuation results.
- Streamlined Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the comprehensive Excel file featuring Bicycle Therapeutics plc's (BCYC) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and analyze results immediately.
- Make Decisions: Leverage the valuation outcomes to inform your investment choices.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investment professionals.
- Comprehensive Data: Bicycle Therapeutics plc’s (BCYC) historical and projected financials integrated for precision.
- Flexible Scenario Analysis: Easily test various forecasts and assumptions with our intuitive interface.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use Bicycle Therapeutics plc (BCYC)?
- Investors: Make informed investment choices with insights into innovative therapies.
- Biotech Analysts: Streamline your research with comprehensive data on pipeline developments.
- Healthcare Consultants: Easily tailor reports and presentations for client needs in the biotech sector.
- Pharmaceutical Enthusiasts: Enhance your knowledge of cutting-edge drug development processes.
- Academics and Students: Utilize it as a valuable resource for studies in biotechnology and pharmaceutical sciences.
What the Template Contains
- Pre-Filled DCF Model: Bicycle Therapeutics plc’s (BCYC) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Bicycle Therapeutics plc’s (BCYC) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.